CSPC Pharmaceutical

HKG:1093 · HK1093012172

PharmaceuticalsX-Large

360

Medium confidence — indicative

Value67

Profit price89

Cash yield1

Sales & asset price47

Price/Sales28

EV / Gross Profit72

Price/Book41

Quality43

Returns on capital29

Return on Capital29

Return on Equity29

Profit margins18

Cash truth not applicable for financial companies.

Growth58

Sales growth89

Profit growth79

Profit Growth100

Long-Term EPS Growth58

Reinvestment63

Price momentum33

Safety—

Debt load87

Debt serviceability43

Liquidity88

Sentiment62

Analyst ratings37

Expectations trend62

Opinion Changes30

Price Target Upside94

Market mood92

Value Creation7/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

CSPC Pharmaceutical clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryChina

IndustryPharmaceuticals

SizeX-Large

TypePublic Company

ExchangeSEHK

Founded1992

Employees25

Websitecspc.com.hk

ISINHK1093012172

Last UpdateApr 2, 2026

Indices

Hang Seng (Hong Kong)

Themes

DiabetesOsteoporosisCardiovascularPain ManagementNeurologyCentral Nervous SystemRespiratoryOncologyBiotechnologyManufacturingPharmaceuticalTherapeutics

Description

CSPC Pharmaceutical Group Limited engages primarily in the development, manufacturing, and distribution of pharmaceutical products. The company operates a diversified range of businesses focused on different therapeutic areas and employs advanced res…

Analysis

Bargain bin

CSPC Pharmaceutical Group Limited falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is uncertain. The company scores 7/20 on our value-creation score: creating some value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare CSPC Pharmaceutical with its peers

Yungjin Pharm

KSC:003520

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Korea United Pharm

KSC:033270

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Dong-A ST

KSC:170900

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Formosa Laboratories

TAI:4746

CountryTaiwan

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

J. B. Chemicals & Pharmaceuticals

NSI:JBCHEPHARM

CountrySingapore

IndustryPharmaceuticals

SizeMedium

Full Stock Analysis →

Hansoh Pharmaceutical

HKG:3692

CountryHong Kong SAR China

IndustryPharmaceuticals

SizeLarge

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →